Skip to main content
NewslettersWatchlist

Stocks in play: HLS Therapeutics Inc.

Baystreet.ca - Baystreet - Wed Aug 28, 8:54AM CDT

Announces that CEO Craig Millian, Chief Executive Officer, will present at H.C. Wainwright's 26th Annual Global Investment Conference, which takes place September 9-11, at the Lotte New York Palace Hotel in New York City. HLS Therapeutics Inc. shares T.HLS are trading unchanged at $3.16.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).